David W. Feigal, M.D., M.P.H. Director Center for Devices and Radiological Health, US Food and Drug Administration

Sep 10, 2012

150 likes | 419 Views

Dr. Lloyd Tepper, Associate Commissioner for Science at FDA in the early 1970's, once characterized DEHP as an etiology in search of a disease". . Assessment of DEHP. The Health Question:Does exposure to PVC medical devices result in adverse health effects ?Risk AssessmentsAmerican Council on Sc

Share Presentation

Embed Code

Link

lavanya

Download Presentation

David W. Feigal, M.D., M.P.H. Director Center for Devices and Radiological Health, US Food and Drug Administration

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

U.S. Food and Drug Administration

U.S. Food and Drug Administration. Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may be outdated. . Summary Data from Animal Clones. Eric S. Dubbin, D.V.M.

756 views • 64 slides

U.S. Food and Drug Administration

332 views • 15 slides

FOOD SAFETY AND SECURITY Operational Risk Management DHHS, US Food and Drug Administration, Center for Food Safety an

FOOD SAFETY AND SECURITY. Vision: Public Health Protection through Safe Food and water sources Strategy: Stop attacks and also reduce vulnerability to them before they occurWe will accomplish this through: Identifying our food assetsIdentify potential threats Use ORM for food s

896 views • 30 slides

Food and Drug Administration

Food and Drug Administration. Drug Regulation BIT 120. FDA. Regulatory body that governs testing and marketing of new therapeutic drugs, food, medical devices and procedures Establishes guidelines for how drugs should be tested in animal studies, as well as clinical trials

346 views • 17 slides

U.S. Food and Drug Administration

U.S. Food and Drug Administration. Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may be outdated. . FluBlok ® Protein Sciences Corporation Presentation.

1.5k views • 112 slides

Solomon Iyasu, M.D., M.P.H. Medical Team Leader DPDD/OCTAP/CDER Food and Drug Administration

Audit of the Columbia Suicidality Classification Project September 13, 2004 Meeting of Psychopharmacological Drugs Advisory Committee and Pediatric Advisory Committee. Solomon Iyasu, M.D., M.P.H. Medical Team Leader DPDD/OCTAP/CDER Food and Drug Administration. Outline. Background

350 views • 21 slides

MEDICAL DEVICES: GOING HOME Food and Drug Administration Center for Devices and Radiological Health June 2004

MEDICAL DEVICES: GOING HOME Food and Drug Administration Center for Devices and Radiological Health June 2004. BACKGROUND. Strategic plan – 2001 Migration of devices into the home Safe and effective use outside of hospital Learn from stakeholders

307 views • 14 slides

Medical Devices - Center for Devices and Radiological Health (CDRH)

Unique Device Identifier Implementation Presented by: Cornelia Rooks Senior Regulatory Specialist Registrar Corp 144 Research Drive Hampton, Virginia USA 23666. Medical Devices - Center for Devices and Radiological Health (CDRH).

618 views • 33 slides

U.S. Food and Drug Administration

U.S. Food and Drug Administration. Food Protection Plan. David W. K. Acheson, M.D., F.R.C.P. Associate Commissioner for Foods. Outline. Why the need for a Food Protection Plan? Changes that need to be addressed regarding imported foods

275 views • 16 slides

Stephen E. Saunders, M.D., M.P.H. Associate Director for Family Health

Impact of Family Case Management and WIC on Birth Outcomes of Medicaid Recipients in Illinois 2000-2002. Stephen E. Saunders, M.D., M.P.H. Associate Director for Family Health Illinois Department of Human Services. Co-authors. Mary Ellen Simpson, R.N., Ph.D. William Sappenfield, M.D., M.P.H.

467 views • 32 slides

U.S. Food and Drug Administration

306 views • 20 slides

Office of Science and Technology Center for Devices and Radiological Health, FDA

eHealth Technologies and the FDA. Office of Science and Technology Center for Devices and Radiological Health, FDA. William A. Herman. Emerging Technology Trends. CDRH TECHNOLOGY FORECAST Computer-related Technology Molecular Medicine Home- and Self-care Minimally Invasive Procedures

309 views • 21 slides

U.S. Food and Drug Administration

U.S. Food and Drug Administration. By: Cameron Bornholm, Angela Jenkins, and Cherelle Waters. Table of Contents. What is the FDA? The job of the FDA Who makes up the FDA FDA’s mission statement Brief History of the FDA Sectors of the FDA Recent Recalls and Alerts. What is the FDA?.

736 views • 32 slides

David G. Brown and Frank Samuelson Center for Devices and Radiological Health, FDA 6 July 2014

Comprehensive Introduction to the Evaluation of Neural Networks and other Computational Intelligence Decision Functions: Receiver Operating Characteristic, Jackknife, Bootstrap and other Statistical Methodologies. David G. Brown and Frank Samuelson Center for Devices and Radiological Health, FDA

1.62k views • 149 slides

U.S. Food and Drug Administration

413 views • 25 slides

Center for Devices and Radiological Health MassMedic May 2006

Center for Devices and Radiological Health MassMedic May 2006. Larry Kessler, Sc.D. Director, Office of Science and Engineering Laboratories, CDRH. The State of the World: CDRH. How are we doing premarket ? How are we doing on compliance efforts? How are we doing on surveillance ?

310 views • 21 slides

U.S. Food and Drug Administration

208 views • 11 slides

Jesse L. Goodman, M.D., M.P.H. Chief Scientist Food and Drug Administration November 14, 2012

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE The Public Health Need for Pandemic Influenza Vaccines. Jesse L. Goodman, M.D., M.P.H. Chief Scientist Food and Drug Administration November 14, 2012. Public Health Impacts of 2009 Pandemic Influenza A (H1N1) and of immunization.

304 views • 9 slides

Food and Drug Administration

Food and Drug Administration. Center for Drug Evaluation and Research. O ffice Building 2. Final Presentation. April 13, 2009. AE Senior Thesis. composed by:. Michael O’Mara Spear. structural option. advisor:. M. Kevin Parfitt. Outline. AE Senior Thesis. Final Presentation.

374 views • 27 slides

David P. Goldman, M.D., M.P.H. Human Health Sciences Division Food Safety and Inspection Service

The Physical Hazards of Foreign Materials Presentation for the Public Meeting on Foreign Material Contamination Sept 24, 2002. David P. Goldman, M.D., M.P.H. Human Health Sciences Division Food Safety and Inspection Service. Objectives.

399 views • 23 slides

Janet Woodcock, MD Director, Center for Drug Evaluation and Research Food and Drug Administration

Today ’ s Biomedical Innovation: “ Lost in Translation”?. QB3 Entrepreneurs ’ Discussion University of California, San Francisco Thursday, April 26, 2012. Janet Woodcock, MD Director, Center for Drug Evaluation and Research Food and Drug Administration.

639 views • 43 slides

Office of Science and Technology Center for Devices and Radiological Health, FDA

218 views • 21 slides

More Related